• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以细胞外基质硬度为靶点进行癌症治疗。

Targeting extracellular matrix stiffness for cancer therapy.

作者信息

Feng Xiuqin, Cao Fujun, Wu Xiangji, Xie Wenyan, Wang Ping, Jiang Hong

机构信息

Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Department of Pancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

Front Immunol. 2024 Dec 2;15:1467602. doi: 10.3389/fimmu.2024.1467602. eCollection 2024.

DOI:10.3389/fimmu.2024.1467602
PMID:39697341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11653020/
Abstract

The physical characteristics of the tumor microenvironment (TME) include solid stress, interstitial fluid pressure, tissue stiffness and microarchitecture. Among them, abnormal changes in tissue stiffness hinder drug delivery, inhibit infiltration of immune killer cells to the tumor site, and contribute to tumor resistance to immunotherapy. Therefore, targeting tissue stiffness to increase the infiltration of drugs and immune cells can offer a powerful support and opportunities to improve the immunotherapy efficacy in solid tumors. In this review, we discuss the mechanical properties of tumors, the impact of a stiff TME on tumor cells and immune cells, and the strategies to modulate tumor mechanics.

摘要

肿瘤微环境(TME)的物理特征包括固体应力、间质液压力、组织硬度和微观结构。其中,组织硬度的异常变化会阻碍药物递送,抑制免疫杀伤细胞向肿瘤部位的浸润,并导致肿瘤对免疫治疗产生抗性。因此,针对组织硬度来增加药物和免疫细胞的浸润,可以为提高实体瘤免疫治疗疗效提供有力支持和机会。在这篇综述中,我们讨论了肿瘤的力学特性、坚硬的肿瘤微环境对肿瘤细胞和免疫细胞的影响,以及调节肿瘤力学的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/d35217d98df2/fimmu-15-1467602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/d324255e1733/fimmu-15-1467602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/3e8199ee5649/fimmu-15-1467602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/d35217d98df2/fimmu-15-1467602-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/d324255e1733/fimmu-15-1467602-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/3e8199ee5649/fimmu-15-1467602-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00d5/11653020/d35217d98df2/fimmu-15-1467602-g003.jpg

相似文献

1
Targeting extracellular matrix stiffness for cancer therapy.以细胞外基质硬度为靶点进行癌症治疗。
Front Immunol. 2024 Dec 2;15:1467602. doi: 10.3389/fimmu.2024.1467602. eCollection 2024.
2
Mechanoimmunology in the solid tumor microenvironment.实体瘤微环境中的机械免疫学。
Biochem Soc Trans. 2024 Jun 26;52(3):1489-1502. doi: 10.1042/BST20231427.
3
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance.放疗诱导肿瘤物理微环境重塑以克服免疫治疗耐药性。
Cancer Lett. 2023 Apr 10;559:216108. doi: 10.1016/j.canlet.2023.216108. Epub 2023 Feb 28.
4
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy.利用生物材料靶向肿瘤微环境以提高免疫治疗效果。
J Nanobiotechnology. 2024 Nov 27;22(1):737. doi: 10.1186/s12951-024-03005-2.
5
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy.靶向肿瘤生物物理微环境以降低对免疫疗法的抗性。
Adv Drug Deliv Rev. 2022 Jul;186:114319. doi: 10.1016/j.addr.2022.114319. Epub 2022 May 8.
6
Biomaterials to regulate tumor extracellular matrix in immunotherapy.免疫疗法中用于调节肿瘤细胞外基质的生物材料。
J Control Release. 2024 Dec;376:149-166. doi: 10.1016/j.jconrel.2024.10.010. Epub 2024 Oct 11.
7
The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies.基质硬度在结直肠癌免疫治疗中的关键作用:机制与治疗策略
Biochim Biophys Acta Rev Cancer. 2024 Nov;1879(6):189198. doi: 10.1016/j.bbcan.2024.189198. Epub 2024 Oct 15.
8
Shifting cold to hot tumors by nanoparticle-loaded drugs and products.通过负载纳米颗粒的药物和产品将冷肿瘤转变为热肿瘤。
Clin Transl Oncol. 2025 Jan;27(1):42-69. doi: 10.1007/s12094-024-03577-3. Epub 2024 Jun 26.
9
Physical oncology: New targets for nanomedicine.实体瘤学:纳米医学的新靶点。
Biomaterials. 2018 Jan;150:87-99. doi: 10.1016/j.biomaterials.2017.10.014. Epub 2017 Oct 6.
10
Beyond matrix stiffness: targeting force-induced cancer drug resistance.超越基质硬度:靶向力诱导的癌症药物耐药性。
Trends Cancer. 2023 Nov;9(11):937-954. doi: 10.1016/j.trecan.2023.07.006. Epub 2023 Aug 8.

引用本文的文献

1
Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance.癌症相关成纤维细胞:与肿瘤浸润免疫细胞的免疫抑制性串扰及其对治疗耐药性的影响
Cancers (Basel). 2025 Jul 28;17(15):2484. doi: 10.3390/cancers17152484.
2
A fetal oncogene NUAK2 is an emerging therapeutic target in glioblastoma.一种胎儿癌基因NUAK2正在成为胶质母细胞瘤的一个新兴治疗靶点。
EMBO Mol Med. 2025 Aug 6. doi: 10.1038/s44321-025-00287-3.
3
Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies.

本文引用的文献

1
Homodimerization of CB cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling.二价配体引发大麻素 CB 受体同源二聚化,增强细胞信号转导。
Pharmacol Res. 2024 Oct;208:107363. doi: 10.1016/j.phrs.2024.107363. Epub 2024 Aug 22.
2
Osr2 functions as a biomechanical checkpoint to aggravate CD8 T cell exhaustion in tumor.Osr2 在肿瘤中作为一个机械生物学检查点加重 CD8 T 细胞耗竭。
Cell. 2024 Jun 20;187(13):3409-3426.e24. doi: 10.1016/j.cell.2024.04.023. Epub 2024 May 13.
3
Palmitic acid in type 2 diabetes mellitus promotes atherosclerotic plaque vulnerability via macrophage Dll4 signaling.
突破物理屏障:改善淋巴细胞浸润以实现有效的基于新抗原疗法的策略。
Front Immunol. 2025 Jun 12;16:1614228. doi: 10.3389/fimmu.2025.1614228. eCollection 2025.
4
Decoding force-transmission linkages for therapeutic targeting and engineering.解码用于治疗靶向和工程的力传递联系。
APL Bioeng. 2025 Jun 13;9(2):021504. doi: 10.1063/5.0267032. eCollection 2025 Jun.
5
Softness or Stiffness What Contributes to Cancer and Cancer Metastasis?柔软还是坚硬?是什么导致了癌症及癌症转移?
Cells. 2025 Apr 12;14(8):584. doi: 10.3390/cells14080584.
棕榈酸在 2 型糖尿病中通过巨噬细胞 Dll4 信号促进动脉粥样硬化斑块易损性。
Nat Commun. 2024 Feb 12;15(1):1281. doi: 10.1038/s41467-024-45582-8.
4
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments.肝细胞癌中肿瘤微环境的复杂性及新兴治疗进展
J Clin Med. 2023 Dec 2;12(23):7469. doi: 10.3390/jcm12237469.
5
circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer.环状 EIF3I 通过募集 SMAD3 到早期内体促进 TGF-β 信号通路介导的 MMPs 在胰腺癌中的激活。
Mol Cancer. 2023 Sep 9;22(1):152. doi: 10.1186/s12943-023-01847-2.
6
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.富含亮氨酸的小分子蛋白聚糖对癌症发病机制的影响概述,重点关注双糖链蛋白聚糖和光蛋白聚糖。
Cancers (Basel). 2023 Jul 9;15(14):3549. doi: 10.3390/cancers15143549.
7
Cancer-associated fibroblasts: from basic science to anticancer therapy.癌相关成纤维细胞:从基础科学到抗癌治疗。
Exp Mol Med. 2023 Jul;55(7):1322-1332. doi: 10.1038/s12276-023-01013-0. Epub 2023 Jul 3.
8
SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunity.SOX9 驱动 KRAS 诱导的肺腺癌进展并抑制抗肿瘤免疫。
Oncogene. 2023 Jun;42(27):2183-2194. doi: 10.1038/s41388-023-02715-5. Epub 2023 May 31.
9
Activated fibroblasts in cancer: Perspectives and challenges.癌症中的激活成纤维细胞:观点和挑战。
Cancer Cell. 2023 Mar 13;41(3):434-449. doi: 10.1016/j.ccell.2023.02.015.
10
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance.放疗诱导肿瘤物理微环境重塑以克服免疫治疗耐药性。
Cancer Lett. 2023 Apr 10;559:216108. doi: 10.1016/j.canlet.2023.216108. Epub 2023 Feb 28.